Whistleblower due $250M in Biogen drug kickback settlement

//Whistleblower due $250M in Biogen drug kickback settlement

Whistleblower due $250M in Biogen drug kickback settlement

Biogen has agreed to pay $900 million to resolve allegations stemming from a whistleblower lawsuit alleging the drugmaker paid kickbacks to physicians to induce them to prescribe the company's multiple sclerosis drugs.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2022-09-27T13:30:21+00:00 September 27th, 2022|Healthcare|

About the Author: